Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injection Moves Through the Body of Healthy Adult Participants
Sponsor: AbbVie
Summary
This study will assess the adverse events, tolerability, and how bretisilocin intramuscular (IM) Injection moves through the body of healthy adult Japanese, Han Chinese, and Non-Asian volunteers participants.
Official title: An Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Dose of Bretisilocin in Healthy Adult Japanese, Han Chinese, and Non-Asian Volunteers
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
26
Start Date
2026-05-26
Completion Date
2026-09-03
Last Updated
2026-09-30
Healthy Volunteers
Yes
Conditions
Interventions
Bretisilocin
Intramuscular Injection
Locations (1)
CenExel Collaborative Neuroscience Research /ID# 281612
Los Alamitos, California, United States